REAL-WORLD USE OF BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN US PATIENTS WITH ANKYLOSING SPONDYLITIS: PERSISTENCE, FACTORS ASSOCIATED WITH DISCONTINUATION, AND DOSING PATTERNS

被引：0

作者：

Dubreuil, M. ^{[1
]}

Walsh, J. A. ^{[2
,3
]}

Deodhar, A. ^{[4
]}

Gensler, L. S. ^{[5
]}

Curtis, J. R. ^{[6
]}

Anjohrin, S. ^{[7
]}

Pilipczuk, O. ^{[8
]}

Tepie, Feudjo M. ^{[9
]}

Beaty, S. ^{[8
]}

Morup, M. ^{[10
]}

Taieb, V ^{[11
]}

Welby, S. ^{[8
]}

机构：

[1] Boston Univ, Sch Med, Boston, MA 02118 USA

[2] Salt Lake City Vet Affairs Hlth, Salt Lake City, UT USA

[3] Univ Utah Hlth, Salt Lake City, UT USA

[4] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[5] Univ Calif San Francisco, San Francisco, CA 94143 USA

[6] Univ Alabama Birmingham, Birmingham, AL USA

[7] UCB Pharma, Tallahassee, FL USA

[8] UCB Pharma, Brussels, Belgium

[9] UCB Pharma, Smyrna, GA USA

[10] UCB Pharma, Copenhagen, Denmark

[11] UCB Pharma, Colombes, France

来源：

VALUE IN HEALTH | 2023年 / 26卷 / 06期

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

RWD136

引用

页码：S386 / S387

页数：2

共 50 条

[41] Incidence and risk factors of discontinuation of tofacitinib and biologic disease-modifying anti-rheumatic drugs among patients with rheumatoid arthritis: A population-based cohort study
Shih, Po-Cheng
Hung, Po-Cheng
Leong, Pui-Ying
Hsu, Jui-Ning
Yang, Chieh-Chun
Wei, James Cheng Chung
Chen, Hsin-Hua
CLINICAL RHEUMATOLOGY, 2024, 43 (12) : 3625 - 3637
[42] Response To Biologic Disease-Modifying Anti-Rheumatic Drugs After Discontinuation Of Anti-Tumor Necrosis Factor Alpha Agents In Rheumatoid Arthritis Patients
Elkin, Eric
Hamburger, Max I.
Kamath, Tripthi
Ogale, Sarika
Turpcu, Adam
Oh, Jae
King, Kristin
Shah, Monarch
Bergman, Martin J.
ARTHRITIS AND RHEUMATISM, 2013, 65 : S212 - S213
[43] Perinatal use and discontinuation of disease-modifying anti-rheumatic drugs and biologics in women with rheumatoid arthritis: a cohort study
Rebic, Nevena
Sayre, Eric C.
Zusman, Enav Z.
Amiri, Neda
Baldwin, Corisande
De Vera, Mary A.
RHEUMATOLOGY, 2020, 59 (07) : 1514 - 1521
[44] A STUDY TO INVESTIGATE FACTORS THAT MAY BE ASSOCIATED WITH PATIENTS' DECISIONS ABOUT STARTING DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS
Skingle, S. J.
RHEUMATOLOGY, 2004, 43 : 153 - 153
[45] Cognitive impairment in elderly patients with rheumatic disease and the effect of disease-modifying anti-rheumatic drugs
Akhil Sood
Mukaila A. Raji
Clinical Rheumatology, 2021, 40 : 1221 - 1231
[46] Recurrent amenorrhoea associated with disease-modifying anti-rheumatic drugs: a case report
Ladhari, C.
Torre, A.
Pers, Y. -M.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (05) : 1035 - +
[47] Cognitive impairment in elderly patients with rheumatic disease and the effect of disease-modifying anti-rheumatic drugs
Sood, Akhil
Raji, Mukaila A.
CLINICAL RHEUMATOLOGY, 2021, 40 (04) : 1221 - 1231
[48] Use of Disease-Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis in Quebec, Canada
Roussy, Jean-Pascal
Bessette, Louis
Bernatsky, Sasha
Rahme, Elham
Legare, Jean
Lachaine, Jean
ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S855 - S855
[49] USE OF DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS FOR RHEUMATOID ARTHRITIS IN QUEBEC, CANADA
Roussy, J. P.
Bessette, L.
Bernatsky, S.
Rahme, E.
Legare, J.
Lachaine, J.
VALUE IN HEALTH, 2011, 14 (07) : A316 - A316
[50] Real-world clinical experience of biological disease modifying anti-rheumatic drugs in Malaysia rheumatoid arthritis patients
Tan, Bee Eng
Lim, Ai Lee
Kan, Sow Lai
Lim, Chong Hong
Tsang, Esther Ee Ling
Ch'ng, Shereen Suyin
Noor, Nadiah Mohd
Jamid, Nurulraziquin Mohd
Teh, Cheng Lay
Thundyil, Rachel Joshua
Loh, Yet Lin
Chong, Hwee Cheng
Ong, Swee Gaik
Ismail, Asmahan Mohamed
Lee, Yvonne Y. L.
Gun, Suk Chyn
RHEUMATOLOGY INTERNATIONAL, 2017, 37 (10) : 1719 - 1725

← 1 2 3 4 5 →